Multimodal magnetic resonance imaging for assessing evolution of ischemic penumbra: A key translational medicine strategy to manage the risk of developing novel therapies for acute ischemic stroke

Journal of Cerebral Blood Flow and Metabolism

Volumn 29, Issue 1, 2009, Pages 217-219

  Chavez, Juan C ^a   Zaleska, Margaret M ^a   Wang, Xinkang ^a   Wood, Andrew ^a   Hurko, Orest ^a   Pangalos, Menelas N ^a   Feuerstein, Giora Z ^a  

^a PFIZER INC   (United States)

Author keywords

Focal ischemia; MR imaging; Neuroprotection; Penumbra; Translational medicine

Indexed keywords

FIBRINOLYTIC AGENT;

BRAIN BLOOD VOLUME; BRAIN NERVE CELL; BRAIN PROTECTION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; FIBRINOLYTIC THERAPY; HUMAN; ISCHEMIC PENUMBRA; NEUROIMAGING; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RISK ASSESSMENT; TISSUE INJURY;

ANIMALS; BRAIN ISCHEMIA; DRUG EVALUATION, PRECLINICAL; HUMANS; MAGNETIC RESONANCE IMAGING; RISK MANAGEMENT; STROKE;

EID: 58149168989     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/jcbfm.2008.103     Document Type: Note

References (10)

1. Ackerman RH, Correia JA, Alpert NM, Baron JC, Gouliamos A, Grotta JC, Brownell GL, Taveras JM (1981) Positron imaging in ischemic stroke disease using compounds labeled with oxygen 15. Initial results of clinicophysiologic correlations. Arch Neurol 38:537-43
2. Baron JC (2005) How healthy is the acutely reperfused ischemic penumbra? Cerebrovasc Dis 20(Suppl 2):25-31
3. Davis SM, Donnan GA, Parsons MW, Levi C, Butcher KS, Peeters A, Barber PA, Bladin C, De Silva DA, Byrnes G, Chalk JB, Fink JN, Kimber TE, Schultz D, Hand PJ, Frayne J, Hankey G, Muir K, Gerraty R, Tress BM, Desmond PM (2008) Effects of alteplase beyond 3 h after stroke in the echoplanar imaging thrombolytic evaluation trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 7:299-309
4. Donnan GA, Fisher M, Macleod M, Davis SM (2008) Stroke. Lancet 371:1612-23
5. Fisher M (2004) The ischemic penumbra: identification, evolution and treatment concepts. Cerebrovasc Dis 17(Suppl 1):1-6
6. Hossmann KA, Kleihues P (1973) Reversibility of ischemic brain damage. Arch Neurol 29:375-84
7. Kane I, Carpenter T, Chappell F, Rivers C, Armitage P, Sandercock P, Wardlaw J (2007) Comparison of 10 different magnetic resonance perfusion imaging processing methods in acute ischemic stroke: effect on lesion size, proportion of patients with diffusion/perfusion mismatch, clinical scores, and radiologic outcomes. Stroke 38:3158-64
8. Kidwell CS, Alger JR, Saver JL (2003) Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke 34:2729-35
9. Santosh C, Brennan D, McCabe C, Macrae IM, Holmes WM, Graham DI, Gallagher L, Condon B, Hadley DM, Muir KW, Gsell W (2008) Potential use of oxygen as a metabolic biosensor in combination with T2(*)-weighted MRI to define the ischemic penumbra. J Cereb Blood Flow Metab 21:1742-53
10. Wintermark M, Albers GW, Alexandrov AV, Alger JR, Bammer R, Baron JC, Davis S, Demaerschalk BM, Derdeyn CP, Donnan GA, Eastwood JD, Fiebach JB, Fisher M, Furie KL, Goldmakher GV, Hacke W, Kidwell CS, Kloska SP, Kohrmann M, Koroshetz W, Lee TY, Lees KR, Lev MH, Liebeskind DS, Ostergaard L, Powers WJ, Provenzale J, Schellinger P, Silbergleit R, Sorensen AG, Wardlaw J, Wu O, Warach S (2008) Acute stroke imaging research roadmap. Stroke 39:1621-8